QNRX - Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.